Navigation Links
Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound
Date:11/3/2009

SAN MARCOS, Texas, Nov. 3 /PRNewswire/ -- Texas State University and Orizon Research Institute announced the signing of an agreement today that will permit University Researchers to continue efforts through in vivo testing to further determine the potential and effectiveness of ALKA-V6, a compound which has shown remarkable ability to kill cancer cells and inhibit the HIV virus in laboratory experiments.

The research will evaluate the effects of ALKA-V6 on animal organisms, and will be highly replicated with the goal of moving knowledge about the compound toward eventual FDA approval.

Dr. Troy Chesnut, Managing Member of Orizon Research Institute, stated, "We are excited to move our research from artificial laboratory systems to animal organisms. These next 18 months of research should confirm previous studies and provide more answers about this promising product."

The prelude from the Texas State University research proposal addresses the reasons for optimism about the product. "ALKA-V6 is a modified value-added silicon compound......This product has been imputed to have several health benefits including anti-microbial activity, bone remodeling and joint health promoting functions as well as chemotherapeutic benefits against cancer and viral infections....In response to numerous testimonials/case studies, empirical evidence and written personal and contractual statements about the putative cancer reducing and alleviation in symptoms associated with several viral diseases, we previously evaluated the anticancer and anti-HIV effects in in vitro models. Our results largely corroborated the empirical observations and many in vitro model systems. ALKA-V6 proved highly effective in mitigating causative factors and conditions that promote cancer and HIV infections. ALKA-V6 was extremely effective in preventing sodium azide induced mutations, cancer cell survival, and cancer cell adhesion. In addition, at very low concentrations, ALKA-V6 was also very effective in promoting apoptosis, preventing free radical mediated DNA damage, activating free radical neutralizing systems such as glutathione, superoxide dismutase and catalase. ALKA-V6 was also very effective in its antiviral activities, and at very low doses it was highly effective in inhibiting viral transcription and replication. In addition, it was also very effective in reducing viral cell attachment and ability of the virus to evade the immune system.

In spite of these scientifically proven effects, most of these studies have been conducted in in vitro systems.....

...Systematic studies need to be conducted in in vivo systems to decipher the genetic and physiological mechanism of action, determine the effective dosages for health promoting activity.....End point measurements as related to modulation of genetic and metabolic pathways relevant to anti-metastatic and anti-retroviral effects are imperative to completely establish the functionality of ALKA-V6 in promoting homeostasis....

The results from this phase of testing may also result in scientific acceptance of the product as an effective alternative/complementary tool for management and prevention of different diseases."

Orizon Research Institute of Odessa, Texas is the international distributor of ALKA V-6. Orizon remains committed to providing the ALKA-V6 compound to the general public as an affordably priced nutritional supplement that can be purchased directly from the company web site. The phase 1 ALKA-V6 research study conducted at Texas State is also available on the Orizon Research web site at www.orizonresearch.com.

CONTACT: Orizon Research, LLC, 1-877-367-7770, media@orizonresearch.com

SOURCE Orizon Research Institute


'/>"/>
SOURCE Orizon Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
2. For creating new field of science, Texas chemist wins international prize
3. Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program
4. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
5. LGE Execs Teams with Texas Tech to License Advancements in Agriculture, Health and Life Sciences
6. Annual List of Best Doctors in Dallas Showcases Texas Institute for Surgery Physicians
7. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
8. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
9. Self-powered devices possible, says Texas A&M researcher
10. NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas
11. Panda Ethanols Hereford, Texas Subsidiary Files Voluntary Chapter 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):